Pfizer

Among leading biotech and emerging pharmaceutical companies, short sellers retreated from Biogen Idec (NASDAQ: BIIB) by the largest percentage in early October. Amgen (NASDAQ: AMGN), Illumina (NASDAQ: ILMN), Regeneron Pharmaceuticals (NASDAQ: REGN) and Seattle Genetics (NASDAQ: SGEN) saw short...

On Sunday, after months of trying to work out a deal, Amgen (NASDAQ: AMGN) and Onyx (NASDAQ: ONXX) announced that Amgen will acquire Onyx for $125 per share valuing the deal as $10.4 billion. The announcement is about as much of a surprise as those two flirtatious coworkers that later told...

This weekend in Barron's online: how to dodge the earnings downdraft, who replaces China as the world's low-cost producer, the prospects for International Speedway, Live Nation Entertainment and Grupo Televisa. Cover Story "Beware Falling Profit Estimates" by Jack Hough. U.S. companies...

Apple (NASDAQ: AAPL), CBS (NYSE: CBS), Merck (NYSE: MRK) and Wal-Mart (NYSE: WMT) all have or are expected to have monster stock repurchase plans of more than $5 billion. Below, we take a quick look at how these stocks have fared and what analysts expect from them. When it comes to returning...

The oil and gas industry will be well represented on this week's earnings stage, with reports due from supermajors Exxon Mobil (NYSE: XOM) and Chevron (NYSE: CVX), and many others in the field. Viacom (NYSE: VIAB) and Comcast (NASDAQ: CMCSA) will be the highlights among the various media companies...

It was a good week for U.S. markets, but going into the weekend, some names gave investors the gift of a compelling technical setup. To get the week started, we compiled five large cap. stocks that crossed above their 50 day moving averages. If you’re looking for some trading ideas for the week,...

Among biotech and emerging pharmaceutical companies, Gilead Sciences (NASDAQ: GILD) and Onyx Pharmaceuticals (NASDAQ: ONXX) saw the most significant rises in short interest between the June 14 and June 28 settlement dates. The number of shares sold short in Amgen (NASDAQ: AMGN), Arena...

Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest between the May 31 and June 14 settlement dates. The number of shares sold short in Onyx Pharmaceuticals (NASDAQ: ONXX), Pharmacyclics (NASDAQ: PCYC) and Regeneron...

Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new team includes recommendations to buy shares of Antares Pharma (NASDAQ: ATRS), Intercept Pharmaceuticals (NASDAQ: ICPT), Questcor Pharmaceuticals (NASDAQ: QCOR) and ViroPharma...

Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares sold short in Amgen (NASDAQ: AMGN), Dendreon (NASDAQ: DNDN), Onyx Pharmaceuticals (NASDAQ: ONXX)...

Among biotech and emerging pharmaceutical companies, Regeneron Pharmaceuticals (NASDAQ: REGN) and Vertex Pharmaceuticals (NASDAQ: VRTX) saw he most significant rise in short interest between the April 30 and May 15 settlement dates. The number of shares sold short in Alexion Pharmaceuticals (...

The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN), Onyx Pharmaceuticals (NASDAQ: ONXX) and VIVUS (NASDAQ: VVUS)...

First-quarter results from General Motors (NYSE: GM) will be one of the highlights on the earnings front this week. Analysts anticipate that the carmaker will say Thursday its revenue slipped about three percent from a year ago to $36.60 billion, but that earnings fell from $0.93 per share a year...

Eli Lilly (NYSE: LLY), which last week announced a deal to buy two imaging agents from Siemens (NYSE: SI) that could help aid the fight against Alzheimer's, is scheduled to report its first-quarter 2013 results Wednesday, April 24, before the markets open. Investors will be watching for the latest...

Question: What can you print with a 3D printer? Answer: Almost anything. Still skeptical? Consider this. Four years ago, restaurant manager Eric Moger, lost almost the entire left side of his face due to emergency cancer surgery. Now, according to The Province, thanks to cutting-edge, three-...